A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive Bladder Cancer

Area of Science:

• Immunology
• Oncology
• Urothelial Carcinogenesis

Background:

• Bladder carcinoma presents significant morbidity and mortality, often due to high recurrence rates in localized stages.
• Understanding the tumor microenvironment's role in bladder cancer development and treatment response is crucial.

Purpose of the Study:

• To investigate the immune cell composition and activation status in the peripheral blood and tumor microenvironment of patients with non-muscle-invasive bladder cancer (NMIBC).
• To identify potential immune markers associated with different grades of bladder cancer and patient outcomes.

Main Methods:

• Collected peripheral blood and tumor samples from 41 patients with low- and high-grade NMIBC.
• Isolated mononuclear cells and performed flow cytometry to analyze T lymphocytes, myeloid cells, and NK cells.
• Examined expression of activation and exhaustion markers on immune cells.

Main Results:

• Detected varying percentages of CD4+, CD8+ lymphocytes, monocytes, and myeloid-derived suppressor cells in blood and tumor samples.
• Observed a significant increase in total bladder monocytes compared to tumor tissue.
• Identified specific peripheral blood markers differentially expressed in patients with different clinical outcomes.

Conclusions:

• Analysis of the host immune response in NMIBC patients can aid in identifying specific markers for optimizing therapy and follow-up.
• Further research is required to develop a robust predictive model based on these immune markers.